Weekly summary of MTRC Instagram account

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better. From the week of February 09th, we plan to work on 17 projects. Review the complete list of planned activities in this post.

Ms. Giselle Balaciano joins MTRC as Evidence Synthesis Specialist, bringing nearly 20 years of expertise in HTA, clinical guideline development, and systematic reviews. As Methodology Advisor to the Argentinian Ministry of Health and trainer with Cochrane Argentina, she has shaped national healthcare policies and contributed to over 100 HTA and evidence synthesis projects published in leading scientific journals. Her appointment significantly enhances MTRC’s ability to deliver high-impact, decision-ready evidence for market access and policy-making. This strengthens MTRC’s role as a trusted partner in advancing evidence-based healthcare decisions across global markets.

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better. From the week of January 26th, we plan to work on 12 projects. Review the complete list of planned activities in this post.

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better. From the week of December 15th, we plan to work on 19 projects. Review the complete list of planned activities in this post.

MTRC has released a White Paper titled "Health Technology Assessment 2015-2024 Trends in Europe". The White Paper is focused on providing a brief description of the health technology assessment (HTA) framework for medical technologies in individual European countries and showcasing trends in Med Tech HTA in individual EU countries.